Main text
Nitric Oxide (NO) fulfils multiple physiological roles, as a signalling agent in neurotransmission and vasodilation, and produces reactive oxygen species responsible for the destruction of pathogens by the immune system [1, 2] . The mammalian NO synthases (NOS) produce NO by the two-step oxidation of L-arginine, via N-hydroxy-arginine, to citrulline, utilising two equivalents of molecular oxygen and one and a half equivalents of NADPH as substrates [3, 4] .
Of the three NOS isoforms in mammals, endothelial NOS (eNOS) and neuronal NOS (nNOS) are expressed constitutively, with their activity being regulated by intracellular Ca 2+ concentration, via the reversible binding of Calmodulin (CaM). The third, inducible NOS (iNOS), binds CaM at low Ca 2+ concentrations and is regulated at the transcriptional level [4] . Each isoform is homodimeric, with subunits that comprise an N-terminal oxygenase domain linked to a C-terminal reductase domain by a CaM binding site (of approximately 20 amino-acids). The reductase domain of one subunit supplies electrons to the oxygenase domain of the other subunit [5, 6] via a large-scale conformational movement, which is integral to the CaM-dependent activation mechanism but is largely undefined.
The oxygenase domain binds a cysteine-ligated heme, tetrahydrobiopterin (H 4 B) and L-arginine, forming the unique active site where oxygen is bound and NO synthesis takes place [7] [8] [9] .
The reductase domain contains FAD, FMN and NADPH, has a structure analogous to that of NADPH-cytochrome P450 reductase (CPR ) [10, 11] , and can be divided into an N-terminal flavodoxinlike domain that binds FMN and a C-terminal FAD domain that is similar to ferrodoxin NADP + reductase (FNR) [12] . Electrons are derived from NADPH dehydrogenation at the FAD and passed sequentially through FMN to the heme in the oxygenase domain. The FMN oscillates between the semiquinone and hydroquinone states during catalysis, serving as a simple one-electron donor [13] , and it is this electron transfer that is both the rate-determining step in NO synthesis and the event activated
by CaM [14] .
The isolated reductase domain (nNOSrd) is also activated by the binding of CaM [15] , with the transfer of electrons to external electron acceptors such as ferricyanide or cytochrome c and NADPHdependent flavin reduction all being accelerated [16] . Given that there is little effect on the reduction potentials of the flavins [17] , it has been proposed that a conformational rearrangement in the reductase domain induced by the binding of CaM is responsible [18, 19] .
There are a number of unique structural features involved in suppressing electron transfer through CaM-free nNOSrd, including a 42 amino-acid insert in the FMN domain [20, 21] , and a 33 residue extension to the C-terminus [22, 23] that have both been shown to be autoinhibitory domains. Deletion of either of these activates electron transfer through the CaM-free reductase domain and synthesis of NO in the holoenzyme [24] . It has recently been proposed that the concerted action of these and bound
Calmodulin are essential for activation [25] . Furthermore, there is a four-to-seven residue insertion in the hinge region between the FMN and FAD domains [26] and phosphorylation sites [27, 28] that have roles in the protection of the CaM-binding linker and in defining the level of Ca 2+ sensitivity of the enzyme.
The binding of NADPH is also important in the Ca 2+ /CaM-dependent regulation of nNOSrd, through its interactions with residues Arg1400 [29] at the 2'-phosphate position, and Phe1395 [30, 31] , which -stacks with the FAD isoalloxazine ring system. When NADPH binds to the CaM-free enzyme, electron transfer from the FMN to external electron acceptors is inhibited; this is thought to be caused by the reductase domain adopting a compact 'locked' conformation in which the FMN is inaccessible [32] .
In the absence of sufficient structural information, the precise mechanism by which CaM activates NO synthase is unclear. However, it appears that CaM-binding induces freedom of conformational motion in the reductase domain, allowing the FMN domain to oscillate between positions in which the FMN is located close to the FAD and close to the heme [41, 42] . The fluidity, speed and size of this movement are unknown. The various autoinhibitory features appear to stabilise the conformation of the protein in which the FMN is close to the FAD, as shown in the crystal structure of nNOSrd ( Fig.   1 ) [11] . This paper addresses the relationship between conformational movement and catalytic action in the reductase domain of nNOS by alteration of the interface between the FAD and FMN domains. A close-up of the interface (Fig. 1) shows the site of an interaction between Arg1229 on the FAD domain and an acidic patch on the FMN domain consisting of Glu762, Glu816 and Glu819. This is one of only two electrostatic contacts between the domains. The arginine residue is conserved in CPR [10] but only interacts with a solitary glutamic acid. In order to destabilise the interface in nNOSrd we mutated Arg1229 to Glu, reversing its charge and introducing a probable electrostatic repulsion.
Kinetic analysis of the mutant shows profound changes to several individual catalytic events, which are interpreted in terms of the above model. Close-up of the interface between the FAD-and FMN-binding domains, with residues Arg1229, Glu762, Glu816, Glu819 in stick conformation.
Experimental procedures
Materials: All reagents were purchased from Sigma Aldrich Ltd, unless otherwise stated.
Generation of the nNOS R1229E mutant:
The R1229E mutation was generated in both full-length rat nNOS and nNOSrd using the Stratagene QuikChange® XL site-directed mutagenesis kit. The templates for the reaction were the nNOS pCWori construct [33] and pCRNNR [34] , respectively. The primers used were R1229EFor (5'GTCCCCTGCTTCGTGGAAGGTGCCCCTAGCTTC) and R1229ERev (5'GAAGCTAGGGGCACCTTCCACGAAGCAGGGGAC) which substitute Arg1229 with glutamic acid. Mismatches are underlined. Products containing the required mutation were selected by automated sequencing. Further sequencing confirmed that no secondary mutations were present. The resulting plasmids pCM199 and pCM226 (containing the R1229E nNOSrd and R1229E nNOS, respectively) were then transferred to E. coli BL21(DE3) for expressing the mutant enzymes. pGroESL [35] , which expresses chaperone proteins, was co-transformed into the E. coli strain with the full-length nNOS mutant.
Preparation of wild-type and R1229E nNOSrd, R1229E nNOS, and Calmodulin: Purification of wild-type and mutant nNOSrd was carried out using 2',5-ADP-agarose (1x20cm) and CaM-agarose (1x10cm), as previously described [32] with the additional use of Protease Inhibitor Cocktail at the cell lysis stage. In order to keep the bound FMN in the semiquinone form, all buffers were degassed with nitrogen prior to use. Enzyme concentration was calculated using an extinction coefficient of 20940 [36] . CaM was purified using the established protocol [32] . R1229E nNOS was purified using 50mM Tris-HCl, pH 7.5, 0.1M KCl, 10% glycerol, 1mM DTT (Buffer A), with the addition of 3 EDTA-free Protease Inhibitor tablets, 1mM PMSF and 4mM H 4 B before sonication on ice. The lysate was centrifuged at 48500g for 1 hour and the supernatant passed through a DEAE column (2x5cm) and eluted with A. CaCl 2 was added to 5mM followed by loading onto a CaM-agarose (1x10cm) column before washing with A + 1mM CaCl 2 and elution with A + 5mM EGTA. Wild-type nNOS was generated in the same manner.
The isolated FMN domain of rat nNOS (nNOSFMNCaM) was coexpressed and copurified with bound calmodulin using anion exchange chromatography as described previously [36] . This mutant consists of residues 695-946 and was always handled in the presence of 1 mM Ca 2+ to ensure bound CaM and to maintain stability. Reduced nNOSFMNCaM was prepared in an anaerobic chamber by reduction using sodium dithionite followed by G25 gel filtration chromatography.
Steady-state turnover:
The activity of nNOSrd was characterised by the reduction of electron acceptors cytochrome c (from Horse Heart) and potassium ferricyanide (FSA Lab supplies) using a Cary 50 UV/Vis or Shimadzu UV-1601 spectrophotometer. Assays were carried out at 25 o C as described previously [21] and initiated by the addition of enzyme /CaM. The change in absorbance at 457nm was monitored and the resultant traces fitted using Origin 7.0 (Microcal). Full spectra were recorded using a diode-array detector, at 2.5 ms intervals. The enzyme was either one-electron reduced by titration against dithionite in an anaerobic glove box (Belle Technology), or fully oxidised by addition of excess potassium ferricyanide followed by size exclusion chromatography (Sephadex G-25).
In the case of inhibition studies, 30M of ferrous cytochrome c was added to the enzyme before mixing. This was prepared by titration with sodium dithionite and removal of excess reductant by size exclusion chromatography (Sephadex G-25).
Cytochrome c reduction:
Stopped-flow cytochrome c reduction experiments were carried out as previously reported [32] , 4M of cytochrome c was mixed with 10M sodium dithionite-reduced nNOSrd in the presence and absence of CaM and the presence and absence of NADPH. Substrate (cytochrome c) inhibition studies were also conducted in the presence of 30M ferrous cytochrome c.
Reduction was observed at 550nm, and pseudo-first order rate constants were calculated by fitting the resultant traces to single exponential functions. Second order rate constants were determined by dividing the pseudo-first order constants by the enzyme concentration. The second order behaviour of this reaction was confirmed for R1229E nNOSrd by varying the concentration of enzyme in the reaction from 7 to 15 M. The rate constant increased linearly with concentration and had a second order constant of 39 mM -1 s -1 as for the wild-type enzyme [32] .
Spectroelectrochemistry: Spectroelectrochemical analysis of nNOSrd was carried out using approximately 0.2 mM enzyme in an OTTTLE cell of 0.2 mm path length as previously described [36] , with the addition of the mediators FMN (15M), benzyl viologen (20M), methyl viologen (30M), 2-hydroxy-1,4-naphthoquinone (30M) and 5-hydroxy-1,4-naphthoquinone (30M). The Ag/AgCl reference electrode was calibrated against indigotrisulfonic acid and FMN and found to be +205 ± 2mV relative to the standard hydrogen electrode (SHE). All electrode potentials were corrected accordingly.
UV-Visible spectra were collected at 30mV intervals in the reductive and oxidative directions, and the absorbance at 456 nm and 540 nm plotted vs applied potential. Both sets of data were fitted simultaneously to a double Nernst-type equation (equation 3) using Origin 7.5 (Microcal). The equation has three parameters: a, b and c representing the absorption coefficients of the flavin oxidized, semiquinone and reduced states respectively. These are allowed to vary at each different wavelength, whereas the 4 reduction potential values are the same at both wavelengths. The FMN and FAD are assumed to have the same extinction coefficients in their respective redox states, which is a good approximation for the wavelengths used according to parameters derived from the single domains [36] . No additional constraints were imposed on the fitting process and convergence was achieved from any reasonable estimate of the parameters prior to fitting. R 2 = 0.99692 and 0.99748
for the wild-type and R1229E data respectively.
NO synthesis: Full-length nNOS was assayed for NOS activity by monitoring the conversion of oxyhemoglobin to methemoglobin at 401 nm, using an extinction co-efficient of 49000 M -1 cm -1
. The reaction was started when nNOS (~20nM) was added to a cuvette containing 10µM oxyhemoglobin, 100µM NADPH, 10units/ml Superoxide dismutase (SoD) and catalase, 10µM
1mM L-Arg, 50g/ml CaM, 1mM CaCl 2 and made up to 1 ml with Tris-HCl (50 mM, pH 7.5) buffer.
NADPH oxidation rates were also collected by monitoring at 340 nm in the absence of oxyhemoglobin, extinction co-efficient 6220 M -1 cm -1
.
Results

Steady-state turnover:
Cytochrome c reduction by nNOS is activated by CaM binding, this effect has been shown to be reproduced in nNOSrd. Rate constants for the steady-state reduction of cytochrome c by wild-type nNOSrd are plotted in Fig. 2A and fitted to the Michaelis-Menten equation. The kinetic parameters are given in Table 1 . The k cat for cytochrome c reduction is enhanced 10-fold upon binding of CaM, as shown previously [16] . 2). The difficulty in obtaining accurate rate constants at low concentrations of cytochrome c compromises the accuracy of these data. It is also impossible to obtain a K m value. The value for k min is the estimated rate constant for steady-state turnover at high cytochrome c concentration (0.9 ± s -1 ) and k max is the rate constant estimated with no inhibition (i.e. the y-axis intercept). Note that the latter value is likely to be underestimated by the fact that decreasing cytochrome c concentrations will cause the observed turnover rate to decrease as the K m is approached. However it is clear that the rate of reduction is markedly slower for R1229E nNOSrd when CaM is bound, an occurrence not seen in other reductase domain mutants, although this is likely to be influenced by the inhibition effect. The overall effect of the mutation on the observed rate of cytochrome c reduction by the CaM-bound enzyme is particularly large; a decrease from 100 s -1 to around 2 s -1 . The mutation therefore appears to induce two separate effects. It decreases the rate of electron transfer through the CaM-bound enzyme and introduces substrate inhibition at high cytochrome c concentrations. Both of these may be due to changes in the electrostatic interactions within the domain interface. In order to test this theory, the assay was repeated at varying levels of ionic strength, i.e. increased NaCl concentration in the assay buffer. Fig. 2C shows a linear dependence of the log of the rate constant for cytochrome c reduction at 15M versus the square root of ionic strength. According to Debye-Huckel theory, the primary kinetic salt effect obtained from the gradient of the plot gives the ionic charge interaction involved. For both the CaM-free and CaM-bound mutant there is a net unit charge interaction of 1. It seems likely therefore that the high salt concentrations can compensate for the negative-negative repulsion across the domain-domain interface caused by the mutated residue and increase the rate of interflavin electron transfer. As expected, the electrostatic component of the interaction is unaltered by the binding of CaM.
When the salt concentration was increased to 1M (Fig. 2D) , the steady-state kinetic data for R1229E nNOSrd fitted to the Michaelis-Menten equation, giving catalytic turnover rates of 25 s -1 (CaM-free) and 9 s -1 (CaM-bound). It is interesting to note that the activity of the enzyme is still decreased by more than 2-fold upon binding of CaM, which is opposite to the effect seen in the wild-type enzyme. Table 1 .
The rate of cytochrome c reduction was measured at 25 o C as detailed in Experimental Procedures and plotted in Fig. 2 . † should be considered a lower estimate, given that the K m could not be obtained. [32] . In these experiments, the enzyme may react further depending on the oxidation state of the FMN; if oxidised, the bound FMN can accept 2 electrons from FAD and allow the FAD to react with a second molecule of NADPH (Scheme 1). During catalysis however, the FMN is bound as an air-stable semiquinone. This form of nNOSrd reacts with NADPH to cause the enzyme to be 3-electron reduced (Scheme 1). Note that electron transfer from FAD to FMN in this state causes little change to the visible spectrum. In order for further reduction of the flavins to occur, intermolecular electron transfer must occur between different enzyme molecules, this is known to occur through disproportionation, probably via the more accessible FMN cofactor [32, 36] .
Data for the reduction of one-electron reduced nNOSrd are shown in Figs. 3A and 3B. The kinetic traces at 457 nm were fitted to double-exponential fitting functions and the derived parameters listed in Table 2 . CaM-free wild-type nNOSrd is reduced by NADPH in a biphasic process with a large slow phase of rate constant 6.5 s -1 . The reduction process observed is undoubtedly hydride transfer from NADPH to FAD, however it is unclear why this is biphasic. The results are consistent across numerous enzyme samples and it is likely that heterogeneity within the sample causes some molecules to react faster than others. CaM-bound wild-type nNOSrd is rapidly reduced by hydride transfer from NADPH at around 100s -1 . This is then followed by further slow reduction initiated by intermolecular electron transfer and disproportionation of flavin semiquinones, this contributes from NADPH to FAD occurs rapidly and is followed by a slow disproportionation phase of similar magnitude. The disproportionation phase can also be observed from the decrease in absorbance at 600 nm (Fig. 3A ) [32] .
It appears that the rate of reduction of FAD by NADPH is faster in CaM-bound nNOSrd than CaMfree and that the R1229E mutant is reduced at least as quickly as the CaM-bound enzyme, regardless of whether CaM is present or not. The mutation therefore appears to increase the rate of FAD reduction by NADPH in the CaM-free enzyme.
Reduction of fully oxidised nNOSrd is complicated by the reaction of the enzyme sequentially with two equivalents of NADPH. Thus hydride transfer from NADPH to FAD is followed by two electron transfers from FAD to FMN before the FAD can react with a second molecule of NADPH (Scheme 1). Kinetic data for the reduction of fully oxidised WT nNOSrd and the R1229E mutant are included in Figs. 3C and 3D. As before, the kinetic traces at 457 nm were fitted to double-exponential fitting functions and the derived parameters listed in Table 2 . From Fig. 3D it is clear that once again CaMbound wild-type nNOSrd is reduced more quickly than CaM-free. However, the rate-constants shown in Table 2 indicate that there is a shift in amplitude for the fast phase from 40 % to 79 % on the addition of CaM rather than an increase in the rate-constant. As with the one-electron reduced enzyme, this indicates that some molecules in the CaM-free sample react faster with NADPH than others. Previous analyses of similar data have failed to reach a satisfactory explanation for the different phases in this reaction [18, 31, 32, 43, 44] and further studies are necessary to explain the full effect of CaM-binding on the NO synthase reductase domain.
For the R1229E mutant, the data are very different and easier to interpret. The kinetic trace in Fig. 3D shows a very rapid first phase, followed by a very slow second phase; a pronounced phase-change is apparent. Both phases contribute 50 % of the absorbance change, (Table 2) indicating that half of the flavins in the sample are reduced in each phase. In order to gain further insight, the absorbance changes at 592 nm should also be considered (Fig. 4) , which report on the formation and loss of flavin semiquinone species during the reduction process. For the CaM-free wild-type enzyme, a rapid increase in semiquinone content is observed, followed by a decrease (Fig 4A) . This is consistent with the transfer of one electron from FAD to FMN (causing the increase) followed by the transfer of a second electron (causing the decrease) as in Scheme 1. For the CaM-bound enzyme the two transfers are faster (Fig. 4B ), leading to a very transient accumulation of semiquinone. The slow increase observed over 4 s is caused by disproportionation of flavins to thermodynamic equilibrium. For the R1229E mutant, the initial build up of semiquinone is much slower than for either CaM-free or CaMbound wild-type enzyme (Fig 4C) for the 2-electron transfer). The electron transfers from FAD to FMN appear therefore to have been dramatically slowed by the mutation, particularly with respect to the CaM-bound wild-type enzyme. It is now clear that the two phases observed in the reduction trace at 457 nm for the R1229E mutant represent the sequential reduction of the FAD and FMN cofactors by two equivalents of NADPH. For the one-electron reduced mutant enzyme, NADPH to FAD hydride transfer has been shown to occur rapidly and completely, whereas for the oxidised enzyme, interflavin electron transfer slows down the reaction with the second equivalent of NADPH and is rate-limiting for this step.
All flavin reduction experiments with the R1229E mutant were repeated in the presence of ferrous cytochrome c, but the hydride transfer step did not appear to be affected (data not shown). Table 2 .
wild-type -FMN semiquinone to >35M -1 s -1 , releasing the lock and allowing the rapid transfer of an electron from FMN to cytochrome c [32] . Addition of an excess of ferrous cytochrome c to the enzyme had no effect on the ability of the ferric cytochrome c to access the bound FMN (data not shown). Spectroelectrochemistry: Potentiometric studies of nNOSrd have previously shown that the FAD is reduced in two one-electron steps of similar potential (approximately -300 mV) and that the FMN is reduced in two one-electron steps with very different potentials (approximately -300 mV and -100 mV) [17, 36] . The FMN semiquinone is thermodynamically stabilised towards oxidation (Table 3) . It also has considerable kinetic stability enabling the FMN to retain the semiquinone oxidation state during purification. Similar reduction potentials are observed in the presence and absence of CaM and even in the isolated FAD and FMN domains. The exception to this is that the FMN semiquinone loses some thermodynamic stability in the isolated domain and shifts to a lower potential. Given that the FMN does not cycle through the semiquinone-oxidised redox couple during catalysis, this is not functionally important. However, it does indicate that the presence of the FAD domain does affect the properties of the FMN.
R1229E nNOSrd was analysed under the same conditions using OTTLE potentiometry. Fig. 6A shows the UV-Visible spectra produced by the stepwise reduction of the mutant by increments of 30mV. The resultant plot of the absorbance at both 457nm and 540nm versus the applied potential ( Fig. 6B ) was fitted using Equation 3, simultaneously fitting both sets of data, and yielding the midpoint reduction potentials given in Table 3 . From these, it can be seen that the only potential This is an indication that the interaction between the two sub-domains is important for the stability of the semiquinone form of bound FMN and is consistent with the effect observed in the isolated FMN domain of a 74 mV shift relative to nNOSrd.
The potentiometric titration of CaM-free wild-type nNOSrd was also repeated using the OTTLE method (Fig. 7) . Previously, this was conducted by chemical reduction [17] . The results are very similar to those reported earlier, although equilibration of this enzyme was particularly slow, requiring 2 hours for each potential step. No evidence for CaM-dependent nNOSrd reduction potentials as reported recently [37] could be found. Table 3 . plotted against applied potential. The data were fitted simultaneously to Eqn 3, yielding the mid-point reduction potentials listed in Table 3 . Table 3 . Midpoint reduction potentials of nNOSrd.
Wild type and R1229E nNOSrd were analysed using OTTLE potentiometry as detailed in NO synthesis: Full-length nNOS, both wild-type and R1229E mutant, were assayed for NOS activity.
There was no CaM-free activity observed for R1229E nNOS, and the CaM-bound activity was approximately 5-fold lower than for the wild-type enzyme. NADPH consumption was decreased by approximately 2.5-fold. Electron flow through the mutant has been destabilised by the mutation, probably resulting in slower flavin to heme electron transfer. Similar studies have been reported for mutations at the same interface in full-length nNOS [38] .
Discussion
Calmodulin (CaM) regulates nNOS by inducing electron transfer through to the heme of the enzyme.
The mechanism of activation is centered on the reductase domain, which undergoes a structural rearrangement on binding CaM, the nature of which is uncertain. In the presence of calcium [3, 4] , CaM binds to a flexible loop of protein connecting the oxygenase and reductase domains together.
Although the structure of the holoenzyme is not known, it is likely that a large-scale motion of the FMN-binding domain is required to induce electron transfer to the heme [18, 19] .
A number of unusual protein inserts not found in the related enzyme, cytochrome P450 reductase, are known to influence the activation process; these include an autoinhibitory loop [20, 21] , a C-terminal extension [22, 23] , a small insertion [26] , and residues that are targeted for kinase-dependent phosphorylation [27, 28] . Alteration of any of these regulatory features activates electron transfer through the CaM-free reductase domain, as measured by the reduction of cytochrome c, but not necessarily to the NOS oxygenase domain. R1229E ( -CaM) -136 ± 6 -279 ± 9 -281 ± 9 -306 ± 9
Isolated domains [36] -179 ± 3 -314 ± 3 -291 ± 3 -326 ± 3 deactivate turnover in the presence of CaM, indicating that the NOS reductase domain is catalytically repressed in the absence of CaM; although deletion of the C-terminal extension produces an enzyme that turns over slightly faster in the presence of CaM [22] . This and mutation of Phe1395 [31] , which facilitates the reaction between NADPH and FAD, both also activate NO synthesis in the CaM-free state. The effect of the R1229E mutation on steady-state cytochrome c reduction by nNOSrd is particularly severe. In the presence of CaM, the enzyme is 30-fold slower than the wild-type and 4-fold slower than in the absence of CaM. This unique shift in behaviour is particularly striking given that only a single charge reversal mutation is involved and appears to be caused by two factors, disruption of FAD to FMN electron transfer and inhibition of this by the electron acceptor cytochrome c.
Arg1229 can be seen in the structure of nNOSrd [11] and in Fig. 1 to interact with a patch of acidic residues on the surface of the FMN domain. Both points of contact are close to the cofactors FMN and FAD (approx. 7 Å) and are likely to be a major factor in holding the cofactors so close together (the FMN and FAD ring systems are separated by only 6 Å). The contact is conserved in cytochrome P450 reductase [12] , suggesting that it functions to orient the two domains effectively for interflavin electron transfer.
It is apparent from the crystal structure of nNOSrd (11) that the autoinhibitory elements involved in repression of the enzyme lie at the interface between the FAD-and FMN-binding domains. It has been speculated that they stabilise a conformation of the CaM-free enzyme in which the FMN is "locked" into a solvent-inaccessible position [25, 29] . This form is also stabilised by the binding of NADPH and is thought to be represented in the crystal structure [11, 32] . All of the mutations listed in Table 4 have multiple effects on the CaM-free enzyme, often characterised by increased cytochrome c reductase activity, faster rates of flavin reduction and decreased response to CaM. It is likely that destabilisation of the FAD-FMN domain interface is a common cause of these effects. Arg1229 is not part of an autoinhibitory feature, or of any other catalytic unit. Therefore, its mutation reports directly on the importance of the interface to the different steps of catalysis.
The catalytic action of nNOSrd involves three primary events: Hydride transfer to FAD, Electron transfer from FAD to FMN and Electron transfer from FMN to heme or surrogate electron acceptor.
Each has been proposed to be activated by CaM [14, 16, 18, 32] . Given the putative role of the autoinhibitory inserts in stabilising the domain-domain interface, and of CaM in counteracting the effect, it seems likely that CaM may affect all three of the steps simultaneously. If the multiple effects of CaM result from destabilisation of the interface, then the R1229E mutation should induce similar
properties. This is the case for hydride transfer from NADPH to FAD and electron transfer to cytochrome c; however the mutation does not activate NO synthesis, which appears to require an additional CaM-dependent structural change not involving the interface directly. The effect on FAD to FMN electron transfer is, on the other hand, more dramatic in the mutant, with little observed effect in the wild-type enzyme on CaM binding
Hydride Transfer: The first chemical step of NO synthesis is the transfer of a hydride from NADPH to FAD. This is most easily monitored by stopped-flow reaction of enzyme with an excess of NADPH. The decrease in the main peak at 456 nm (Fig. 3) reports primarily on flavin reduction originating from hydride transfer to the FAD. As the data in Fig. 3B confirm, CaM increases the rate of hydride transfer in fully oxidised wild-type nNOSrd, although the actual rate constants determined from fitting the data show a shift in the amplitudes from the slow to the fast kinetic phases rather than a large change in the rate constants ( Table 2 ). Note also that two consecutive reactions with NADPH occur with this enzyme form. For the R1229E mutant the results are more obvious, with two exponentials of equal amplitude, it is clear that the first hydride transfer is fast and the second is slow.
The reason for this is a slow interflavin electron transfer step occurring between the two hydride transfers. Note that it is apparent from Table 2 indicate that the rate constants for both hydride and interflavin electron transfer increase by at least an order of magnitude when the appropriate conformation is stabilised.
CT deletion [22] 130 % a the k cat value + CaM is affected by cyt c inhibition and this value is therefore an overestimate. Table 4 . CaM-dependence of steady-state cytochrome c reduction by nNOSrd and mutants.
Interflavin electron transfer:
The fact that cytochrome c is able to inhibit interflavin electron transfer in the mutant enzyme suggests that the FAD and FMN domains separate enough to allow another protein to access the interface. This indicates that the FMN domain is able to move a large distance during catalysis, which may be a feature of electron transfer to the NOS heme in the holoenzyme. In in the hinged-closed form is likely to be very rapid over the 6 Å distance reported in the crystal structure, such that the hinge closed form may only need to be sampled briefly to maintain turnover.
Mutation of the acidic patch interface residues Glu816 and Glu762 (and R1229) has recently been shown to activate electron transfer through CaM-free nNOS and to slow the rate of electron transfer to nNOS heme [38] . It has been speculated that the same residues interact with a basic patch on the oxygenase domain, including Lys423. Mutation of this residue has also been shown to affect the rate of NO synthesis [39] . None of these mutations, or the R1229E mutant described here, result in the activation of NO synthesis in CaM-free nNOS. Thus, there is no direct correlation between the strength of interaction across the FMN-FAD domain interface and NO synthesis activity, although k cat (CaM-free) / k cat (CaM-bound)
Wild-type 10 % SI deletion [26] 25 % AI deletion [21] 40 % R1400E [29] 70 % F1395S [31] 85 % R1229E releasing the "conformational lock" exhibited by nNOS reductase domain, CaM also appears to remove a "hinge stop", which prevents the two domains from swinging further apart. Such large-scale motion may be necessary for the FMN to deliver an electron to the heme. Various candidates for this structural feature are the autoinhibitory elements mentioned previously.
In summary, the R1229E mutation disrupts the FAD-FMN domain interface in nNOSrd such that there is no regulatory interaction between the two domains. Electron transfer from FAD to FMN is severely retarded and hydride transfer from NADPH to FAD is accelerated, particularly when compared to the CaM-free wild-type enzyme. This is consistent with a model for the catalytic action of the enzyme in which it exists in two conformational states, "closed" and "open", with distinct kinetic events happening in each state (Fig. 8) . 
